Cargando…
Erratum to: Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
Autores principales: | Stockfleth, Eggert, von Kiedrowski, Ralph, Dominicus, Rolf, Ryan, John, Ellery, Adam, Falqués, Meritxell, Ivanoff, Nathalie, Azeredo, Rosario Rodriguez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453921/ https://www.ncbi.nlm.nih.gov/pubmed/28421455 http://dx.doi.org/10.1007/s13555-017-0179-0 |
Ejemplares similares
-
Efficacy and Safety of 5-Fluorouracil 0.5%/Salicylic Acid 10% in the Field-Directed Treatment of Actinic Keratosis: A Phase III, Randomized, Double-Blind, Vehicle-Controlled Trial
por: Stockfleth, Eggert, et al.
Publicado: (2016) -
Evaluating the Efficacy and Safety of 4% 5-Fluorouracil Cream in Patients with Actinic Keratosis: An Expert Opinion
por: STOCKFLETH, Eggert, et al.
Publicado: (2023) -
Intensity of Local Skin Reactions During 5-Fluorouracil Treatment Related to the Number of Actinic Keratosis Lesions: A Post Hoc, Exploratory Analysis
por: Stockfleth, Eggert, et al.
Publicado: (2021) -
Efficacy Endpoints in Clinical Trials in Actinic Keratosis
por: Skov, Torsten, et al.
Publicado: (2018) -
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial
por: Stockfleth, Eggert, et al.
Publicado: (2023)